BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
67 results:

  • 1. Establishment and characterization of a novel patient-derived Ewing sarcoma cell line, NCC-ES2-C1.
    Yoshimatsu Y; Noguchi R; Sin Y; Tsuchiya R; Ono T; Akiyama T; Nakagawa R; Kamio S; Hirabayashi K; Ozawa I; Kikuta K; Kondo T
    Hum Cell; 2022 Jul; 35(4):1262-1269. PubMed ID: 35441357
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
    Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
    Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of Somatic Mutations in Driver Genes of Resected pancreatic Ductal Adenocarcinoma Reveals KRAS G12D and Mutant TP53 Combination as an Independent Predictor of clinical outcome.
    Shoucair S; Habib JR; Pu N; Kinny-Köster B; van Ooston AF; Javed AA; Lafaro KJ; He J; Wolfgang CL; Yu J
    Ann Surg Oncol; 2022 Apr; 29(4):2720-2731. PubMed ID: 34792696
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors.
    Altieri B; Barrea L; Modica R; Bottiglieri F; de Cicco F; Muscogiuri G; Circelli L; Savarese G; Di Somma C; Savastano S; Colao A; Faggiano A
    Endocrine; 2022 Feb; 75(2):623-634. PubMed ID: 34533768
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
    Luo Y
    Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Scoring of tumour response after neoadjuvant therapy in resected pancreatic cancer: systematic review.
    van Roessel S; Janssen BV; Soer EC; Fariña Sarasqueta A; Verbeke CS; Luchini C; Brosens LAA; Verheij J; Besselink MG
    Br J Surg; 2021 Mar; 108(2):119-127. PubMed ID: 33711148
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms.
    Liverani C; Bongiovanni A; Mercatali L; Pieri F; Spadazzi C; Miserocchi G; Di Menna G; Foca F; Ravaioli S; De Vita A; Cocchi C; Rossi G; Recine F; Ibrahim T
    Endocr Pathol; 2021 Jun; 32(2):309-317. PubMed ID: 33409812
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma.
    Luang S; Teeravirote K; Saentaweesuk W; Ma-In P; Silsirivanit A
    Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33207685
    [No Abstract]    [Full Text] [Related]  

  • 9. Pattern of Invasion in Human pancreatic cancer Organoids Is Associated with Loss of SMAD4 and clinical outcome.
    Huang W; Navarro-Serer B; Jeong YJ; Chianchiano P; Xia L; Luchini C; Veronese N; Dowiak C; Ng T; Trujillo MA; Huang B; Pflüger MJ; Macgregor-Das AM; Lionheart G; Jones D; Fujikura K; Nguyen-Ngoc KV; Neumann NM; Groot VP; Hasanain A; van Oosten AF; Fischer SE; Gallinger S; Singhi AD; Zureikat AH; Brand RE; Gaida MM; Heinrich S; Burkhart RA; He J; Wolfgang CL; Goggins MG; Thompson ED; Roberts NJ; Ewald AJ; Wood LD
    Cancer Res; 2020 Jul; 80(13):2804-2817. PubMed ID: 32376602
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The expression landscape of cachexia-inducing factors in human cancers.
    Freire PP; Fernandez GJ; de Moraes D; Cury SS; Dal Pai-Silva M; Dos Reis PP; Rogatto SR; Carvalho RF
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):947-961. PubMed ID: 32125790
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The impact of diabetes mellitus on clinical outcomes following chemotherapy for the patients with pancreatic cancer: a meta-analysis.
    Ma J; Wang J; Ge L; Long B; Zhang J
    Acta Diabetol; 2019 Oct; 56(10):1103-1111. PubMed ID: 31069497
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Practical Contribution of Virtual Hepatectomy for Colorectal Liver Metastases: a Propensity-Matched Analysis of clinical outcome.
    Takamoto T; Sano K; Hashimoto T; Ichida A; Shimada K; Maruyama Y; Makuuchi M
    J Gastrointest Surg; 2018 Dec; 22(12):2037-2044. PubMed ID: 29980979
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Nivolumab-induced thyroid dysfunction in patients with lung cancer.
    Ramos-Levi AM; Rogado J; Sanchez-Torres JM; Colomer R; Marazuela M
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Jan; 66(1):26-34. PubMed ID: 29910159
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic role of platelet to lymphocyte ratio in pancreatic cancers: A meta-analysis including 3028 patients.
    Li W; Tao L; Lu M; Xiu D
    Medicine (Baltimore); 2018 Feb; 97(8):e9616. PubMed ID: 29465553
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
    Phua LC; Goh S; Tai DWM; Leow WQ; Alkaff SMF; Chan CY; Kam JH; Lim TKH; Chan ECY
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):277-289. PubMed ID: 29196965
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
    Liu FT; Dong Q; Gao H; Zhu ZM
    Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
    Klieser E; Urbas R; Stättner S; Primavesi F; Jäger T; Dinnewitzer A; Mayr C; Kiesslich T; Holzmann K; Di Fazio P; Neureiter D; Swierczynski S
    Hum Pathol; 2017 Jul; 65():41-52. PubMed ID: 28235630
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Stage IV Gastro-Entero-pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict clinical outcome.
    Panzuto F; Merola E; Pavel ME; Rinke A; Kump P; Partelli S; Rinzivillo M; Rodriguez-Laval V; Pape UF; Lipp R; Gress T; Wiedenmann B; Falconi M; Delle Fave G
    Oncologist; 2017 Apr; 22(4):409-415. PubMed ID: 28232598
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Impact of Vitamin D on the clinical outcome of Gastro-Entero-pancreatic Neuroendocrine Neoplasms: Report on a Series from a Single Institute.
    Massironi S; Zilli A; Bernasconi S; Fanetti I; Cavalcoli F; Ciafardini C; Felicetta I; Conte D
    Neuroendocrinology; 2017; 105(4):403-411. PubMed ID: 28122374
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Enucleation versus hepatectomy for giant hepatic haemangiomas: a meta-analysis.
    Cheng WL; Qi YQ; Wang B; Tian L; Huang W; Chen Y
    Ann R Coll Surg Engl; 2017 Mar; 99(3):237-241. PubMed ID: 27869486
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.